Please check the individual session for location or broadcast availability.
Laura Meza Rios, MD
Target Audience and Needs
Medical oncologists, surgical oncologists, radiation oncologists, fellows, residents, physician assistants, nurses, and social workers need to receive regular updates on advances in the diagnosis, staging, and treatment of cancer. The tumor board will use a multidisciplinary team forum to review and evaluate cancer care protocols, treatment algorithms, and evidence-based results of clinical trials. It aims to enhance the quality of cancer care, promote more effective consultation methods, facilitate better communication with patients, and improve patient outcomes.
Educational methods will include case presentations, literature review, and roundtable discussions.
At the conclusion of the sessions, the participants should be able to:
- Distinguish between resectable and unresectable tumors and locally advanced and metastatic disease.
- Apply appropriate treatment algorithms based on tumor type.
- Review and evaluate ongoing cancer clinical trials for evidence-based recommendations.
- Use a multidisciplinary team approach to improve consultation practices and the continuum of care for patients with cancer.
Participants may be asked to complete a session evaluation.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.